Concepedia

Author

Toshiyuki Sakai

Kyoto Prefectural University of Medicine

Also Known As

T Sakai, Toshiyuki Sakai

11

Publications

493

Citations

10

H-Index

31

Concepts

All Affiliations

Kyoto Prefectural University of MedicineTokyo Institute of Technology
TS

About

Toshiyuki Sakai is an author at Kyoto Prefectural University of Medicine specializing in medicine, cell biology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

424

2

Cell Biology

6

6

403

3

Pathology

2

2

84

4

Health Sciences

1

1

35

5

Molecular Biology

1

1

213

Toshiyuki Sakai

×

10

Publications

493

Citations

10

H-Index

YearCitations

Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites

Lili Huang, Yoshihiro Sowa, Toshiyuki Sakai,

Oncogene

2000

213

The Flavonoid Apigenin Downregulates CDK1 by Directly Targeting Ribosomal Protein S9

Yosuke Iizumi, Masakatsu Oishi, Tomoyuki Taniguchi,

PLoS ONE

2013

49

Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells

Ryoichi Tanaka, Mitsuhiro Tomosugi, Mano Horinaka,

PLoS ONE

2015

49

Genistein induces Gadd45 gene and G <sub>2</sub> /M cell cycle arrest in the DU145 human prostate cancer cell line

Teruki Oki, Yoshihiro Sowa, Tohru Hirose,

FEBS Letters

2004

46

Resibufogenin Induces G1-Phase Arrest through the Proteasomal Degradation of Cyclin D1 in Human Malignant Tumor Cells

Masami Ichikawa, Yoshihiro Sowa, Yosuke Iizumi,

PLoS ONE

2015

35

Retinoblastoma binding factor 1 site in the core promoter region of the human RB gene is activated by hGABP/E4TF1.

Yoshihiro Sowa, Yuzuru Shiio, Tsuyoshi Fujita,

PubMed

1997

33

Blockage of the mevalonate pathway overcomes the apoptotic resistance to MEK inhibitors with suppressing the activation of Akt in cancer cells

Mahiro Iizuka-Ohashi, Motoki Watanabe, Mamiko Sukeno,

Oncotarget

2018

24

Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma

Nobuhisa Hagiwara, Motoki Watanabe, Mahiro Iizuka-Ohashi,

Cancer Letters

2018

21

Three Combined Treatments, a Novel HDAC Inhibitor OBP-801/YM753, 5-Fluorouracil, and Paclitaxel, Induce G<sub>2</sub> Phase Arrest Through the p38 Pathway in Human Ovarian Cancer Cells

Makoto Akiyama, Yoshihiro Sowa, Tomoyuki Taniguchi,

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

2017

13

IgG4-related disease that presented cranial, cervical, lumbar and sacral hypertrophic pachymeningitis associated with infundibulo-hypophysitis

Toshiyuki Sakai, Masahide Kondo, Shintaro Yoshii,

Rinsho Shinkeigaku

2014

10

Page 1